| abstract |
The present invention relates to pharmaceutical compositions for administration by intramuscular or subcutaneous injection, comprising micro or nanoparticles of the anti-TB bedaquiline compound, in suspension in a pharmaceutically acceptable aqueous vehicle, and the use of such pharmaceutical compositions in the treatment and prevention of a pathogenic mycobacterial infection. |